Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone-induced hyperglycaemia insulin regimen trial
ACTRN12612000817842Phase 4Completed
- Sponsor
- Dr Morton Burt
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisolone, insulin isophane, insulin aspart and insulin glargine in hyperglycemia (2 arms), sponsored by Dr Morton Burt. Primary endpoint: Time outside glucose target range. Started Aug 2012; status: completed.
02
Drugs
prednisoloneinsulin isophaneinsulin aspartinsulin glargine
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on ACTRN12612000817842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000817842.